AI Article Synopsis

  • Fragile X syndrome (FXS) is a genetic disorder caused by an expansion of CGG repeats in the FMR1 gene, affecting neurodevelopment and passed on through female carriers who have a premutation (PM).
  • A study in Thailand analyzed 1250 reproductive-age women, discovering a low prevalence of PM carriers at about 0.17% and identifying three women with gray zone alleles (0.25%).
  • The findings emphasize the need for PM carrier screening among women of reproductive age to improve family planning and reproductive health, particularly to mitigate risks like fragile X-associated primary ovarian insufficiency (FXPOI).

Article Abstract

Purpose: Fragile X syndrome (FXS) is a neurodevelopmental disorder, caused by an CGG repeat expansion (FM, > 200 CGG) in the fragile X messenger ribonucleoprotein 1 (FMR1) gene. Female carriers of a premutation (PM; 55-200 CGG) can transmit the PM allele, which, depending on the CGG allele size, can expand to an allele in the FM range in the offspring.

Methods: Carrier screening for FMR1 PM is not available in Thailand. This study aimed to investigate the prevalence of PM carriers among Thai reproductive women at the tertiary hospital. A total of 1250 females participated in this study; ages ranged from 20 to 45 years, mean of 30 years (S.D. = 6.27).

Results: Two carriers of a premutation allele, with 32,62 and 32,69 CGG repeats respectively, were identified. This corresponds to 1 in 600 women or 0.17% of the population. Further, three women carrying a gray zone allele (45-54 CGG repeats) were identified (29,51; 29,49; and 30,47 CGG repeats) which equals to 1:400 women or 0.25% of the population. No FM case was detected.

Conclusions: This study heightens the importance of PM carrier screening of women of reproductive age, particularly for the higher risk of developing fragile X-associated primary ovarian insufficiency (FXPOI). Early identification of PM carrier status enhances family planning and fecundity alternatives and improves reproductive health outcomes leading to a better life.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621265PMC
http://dx.doi.org/10.1007/s10815-024-03242-2DOI Listing

Publication Analysis

Top Keywords

carrier screening
12
cgg repeats
12
reproductive women
8
carriers premutation
8
repeats identified
8
cgg
7
women
6
allele
5
population-based fmr1
4
carrier
4

Similar Publications

Cystic fibrosis carrier screening in Australia: comparing sequencing and targeted panels across diverse ancestries.

J Med Genet

December 2024

Molecular Genetics, Virtus Diagnostics, Revesby, New South Wales, Australia.

Background: Targeted cystic fibrosis (CF) carrier screening panels may lack sensitivity in non-European ancestry groups. This study aims to evaluate the sensitivity of various panels in Australian CF carriers identified through sequencing.

Methods: The following panels were evaluated in 869 CF carriers: Asuragen, Elucigene, Devyser, American College of Medical Genetics and Genomics and Victorian Clinical Genetics Services.

View Article and Find Full Text PDF

Design of cerium dioxide anchored in cobalt-iron layered double hydroxide hollow polyhedra via an ion exchange strategy for the oxygen evolution reaction.

J Colloid Interface Sci

December 2024

State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Key Laboratory of Analytical Science and Technology of Hebei Province, College of Chemistry and Materials Science, Hebei University, 071002 Baoding, PR China. Electronic address:

The oxygen evolution reaction (OER) is hindered by slow kinetics due to its four-electron process, limiting overall efficiency. The rational design of metal-organic framework (MOF)-based nanomaterials is crucial for enhancing the oxygen production rate. Using a straightforward strategy, we synthesized cobalt-iron layered double hydroxide (CoFe-LDH) hollow polyhedra loaded with CeO, with zeolite imidazolate framework-67 (ZIF-67) serving as the precursor.

View Article and Find Full Text PDF

A multifunctional graphene oxide-based nanodrug delivery system for tumor targeted diagnosis and treatment under chemotherapy-photothermal-photodynamic synergy.

Colloids Surf B Biointerfaces

December 2024

Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China. Electronic address:

Traditional cancer therapies, such as chemotherapy, often lack specificity, resulting in severe toxic side effects and limited therapeutic efficacy. There is an urgent need to develop innovative multifunctional nanomedicine carriers that integrate precise diagnosis, targeted therapy, real-time monitoring, and the synergistic effects of multiple therapeutic approaches. In this study, a composite nanodrug delivery system (GO-HA-Ce6-GNRs) based on graphene oxide (GO) was innovatively prepared, which was functionalized with the targeting molecule hyaluronic acid (HA), the photosensitizer chlorin e6 (Ce6), and the photothermal material gold nanorods (GNRs).

View Article and Find Full Text PDF

Constitutional platelet disorders have become better understood since Bernard and Soulier first described a case in 1948. Their diagnosis can also be challenging due to overlap in clinical presentation and lab findings with platelet type von Willebrand. Bernard-Soulier syndrome is a disorder caused by GPIb receptor mutations that decrease its affinity for von Willebrand factor resulting in reduced platelet function and macrothrombocytopenia.

View Article and Find Full Text PDF

Background And Objective: Recently, RAB32 has been identified as possibly linked to Parkinson's disease. We studied the prevalence and clinical correlates of the p.Ser71Arg variant in the RAB32 gene in a large case series of Italian patients with Parkinson's disease or atypical parkinsonism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!